MARSHALL WACE, LLP - NOVAVAX INC ownership

NOVAVAX INC's ticker is NVAX and the CUSIP is 670002401. A total of 412 filers reported holding NOVAVAX INC in Q2 2021. The put-call ratio across all filers is 1.03 and the average weighting 0.2%.

Quarter-by-quarter ownership
MARSHALL WACE, LLP ownership history of NOVAVAX INC
ValueSharesWeighting
Q2 2022$8,235,000
+575.6%
160,157
+867.5%
0.02%
+750.0%
Q1 2022$1,219,000
-81.3%
16,554
-63.7%
0.00%
-83.3%
Q4 2021$6,522,000
+98.4%
45,591
+187.5%
0.01%
-14.3%
Q3 2021$3,288,000
-62.1%
15,860
-61.2%
0.01%
-64.1%
Q2 2021$8,684,000
-5.6%
40,905
-19.4%
0.04%
-7.1%
Q1 2021$9,202,000
+2766.7%
50,758
+1664.3%
0.04%
+2000.0%
Q4 2020$321,0002,8770.00%
Other shareholders
NOVAVAX INC shareholders Q2 2021
NameSharesValueWeighting ↓
RA Capital Management 4,758,833$396,649,0007.73%
TSP Capital Management Group, LLC 72,575$6,049,0002.58%
Beirne Wealth Consulting Services, LLC 22,250$1,855,0001.51%
DISCOVERY CAPITAL MANAGEMENT, LLC / CT 93,000$7,752,0001.41%
Rock Springs Capital Management LP 570,598$47,559,0001.30%
Sargent Investment Group, LLC 38,059$3,033,0001.14%
Harvest Investment Services, LLC 19,580$1,631,0000.97%
Parkman Healthcare Partners LLC 40,000$3,334,0000.94%
EAM Investors, LLC 39,055$3,255,0000.72%
EAM Global Investors LLC 17,774$1,481,0000.67%
View complete list of NOVAVAX INC shareholders